Literature DB >> 11839645

Protein kinase A type I: a target for cancer therapy.

Giampaolo Tortora, Fortunato Ciardiello.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839645

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

1.  Increase of cytosolic calcium induced by trichosanthin suppresses cAMP/PKC levels through the inhibition of adenylyl cyclase activity in HeLa cells.

Authors:  Qingsong Jiang; Tumen Bai; Shunhua Shen; Lei Li; Haoliang Ding; Ping Wang
Journal:  Mol Biol Rep       Date:  2010-11-19       Impact factor: 2.316

2.  Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase.

Authors:  Deepti Chaturvedi; Helen M Poppleton; Teresa Stringfield; Ann Barbier; Tarun B Patel
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

3.  Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling.

Authors:  Lisa C Loram; Frederick R Taylor; Keith A Strand; Jacqueline A Harrison; Rachael Rzasalynn; Paige Sholar; Jayson Rieger; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2013-06-28       Impact factor: 7.217

4.  Mitochondrial function, apoptosis and cell cycle delay in the WEHI-3B leukaemia cell line and its variant Ciprofloxacin-resistant WEHI-3B/CPX.

Authors:  A Pessina; A Bonomi; S Casati; A Collotta; C Croera; E Marafante; F Palitti; L Gribaldo
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

5.  A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer.

Authors:  Shikha Saini; Nirmala Jagadish; Anju Gupta; Amar Bhatnagar; Anil Suri
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.